US FDA Personnel Costs Drop: Is The Next Generation Taking Over?
The agency sees its personnel compensation and benefits costs decrease for the first time in at least 16 years, while the overall FTE count continues to rise.
You may also be interested in...
US FDA Hiring Strategy Shifts Focus From ‘Vacancies’ To ‘Net Gains’
As outside report urges increased planning and culture changes, FDA OTS Director Keller says recruitment will stop ‘order taking’ and move to ‘forecasting the hiring needs of each of the centers.’
PDUFA Needs More Than 300 Additional FTEs, New US FDA Capacity Planning Formula Says
But the agency chose to fund only a small fraction of them, in part because of its hiring ability, and in part because all those employees would have cost an additional $98.7m in user fee revenue.
US FDA's Biologics Center May Get Its Day In PDUFA VII
Multiple stakeholders call for CBER to receive more prescription drug user fee funds amid growing cell and gene therapy popularity.